Evidence map›Paper›PMID 34242045›Full record

ArticleNeuropsychology2021

Adaptation and validation of a computerized neurocognitive battery in the Xhosa of South Africa.

J Cobb Scott, Tyler M Moore, Dan J Stein, Adele Pretorius, Zukiswa Zingela, Mohammed Nagdee, Linda Ngqengelele, Megan Campbell, Goodman Sibeko, Mary Claire King and 6 more

Open access · greenAbstract read
In one paragraph

Article in Neuropsychology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Test-Retest Reliability of a Computerized Neurocognitive Battery in School-Age Children with HIV in Botswana.Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists · 2023
    Article
  8. Article
  9. Cognitive Impairment in Acute Heart Failure: Narrative Review.Journal of cardiovascular development and disease · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 2 countries.

J Cobb ScottBrain Behavior Laboratories, Department of Psychiatry, University of Pennsylvania Perelman School of Medicine.ORCID 0000-0001-6538-9043
Tyler M MooreBrain Behavior Laboratories, Department of Psychiatry, University of Pennsylvania Perelman School of Medicine.ORCID 0000-0002-1384-0151
Dan J SteinDepartment of Psychiatry and Mental Health, University of Cape Town.ORCID 0000-0001-7218-7810
Adele PretoriusDepartment of Psychiatry and Mental Health, University of Cape Town.
Zukiswa ZingelaDepartment of Psychiatry and Mental Health, University of Cape Town.ORCID 0000-0002-3425-1145
Mohammed NagdeeDepartment of Psychiatry and Mental Health, University of Cape Town.ORCID 0000-0001-8227-5611
Linda NgqengeleleDepartment of Psychiatry and Mental Health, University of Cape Town.ORCID 0000-0002-3084-1631
Megan CampbellDepartment of Psychiatry and Mental Health, University of Cape Town.ORCID 0000-0001-9576-8562
Goodman SibekoDepartment of Psychiatry and Mental Health, University of Cape Town.
Mary Claire KingDepartment of Medicine, University of Washington.
Jon M McClellanDepartment of Medicine, University of Washington.ORCID 0000-0002-0101-1073
Allison M PortBrain Behavior Laboratories, Department of Psychiatry, University of Pennsylvania Perelman School of Medicine.ORCID 0000-0003-0783-6487
Chad JacksonBrain Behavior Laboratories, Department of Psychiatry, University of Pennsylvania Perelman School of Medicine.
Kosha RuparelBrain Behavior Laboratories, Department of Psychiatry, University of Pennsylvania Perelman School of Medicine.
Ezra S SusserDepartment of Epidemiology, Mailman School of Public Health, Columbia University.
University of Cape Town · ZAUniversity of Pennsylvania · USUniversity of Washington · USColumbia University · US

Funding

Evolution of Psychosis in Youth: Multimodal Risk and Resilience MarkersR01MH119219 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI GUR, RAQUEL E, GUR, RUBEN C. · 2019 to 2023
$3.8M
Creating an adaptive screening tool for detecting neurocognitive deficits and psychopathology across the lifespanR01MH117014 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI GUR, RUBEN C. · 2019 to 2022
$2.9M
The Ancestral Populations Network Phenotypic Harmonization Working Group Administrative Supplement: 2/3 Genomics of Schizophrenia in the South African XhosaU01MH125058 · NIMH · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI WALL, MELANIE M · 2021 to 2025
$2.5M
1/3 - Genomics of Schizophrenia in the South Africa XhosaU01MH096756 · NIMH · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SUSSER, EZRA S. · 2013 to 2017
$1.8M
NIMH NIH HHS R01 MH117014NIMH NIH HHS R01 MH119219NIMH NIH HHS U01 MH096756NIMH NIH HHS U01 MH125058
6 · The paper itself

Abstract

objectiveLarge-scale studies have revolutionized biomedical research, and neurocognitive tests can help elucidate the biological basis of neuropsychiatric diseases. However, studies have predominantly been conducted in Western settings. We describe the development and validation of a computerized battery (PennCNB) with the Xhosa population of South Africa.

methodIndividuals with schizophrenia (n = 525) and a normative comparison group (n = 744) were balanced on age, sex, education, and region. Participants provided blood samples, were assessed psychiatrically, and were administered a PennCNB translation to isiXhosa, including measures of executive functions, episodic memory, complex cognition, social cognition, and sensorimotor speed. Feasibility was examined with test completion rates and input from administrators, and psychometric structural validity and associations with clinical and demographic characteristics were examined.

resultsTests were well tolerated by participants, as >87% had one (or fewer) test missing. Results suggested a similar factor structure to prior PennCNB studies in Western contexts, and expected age and sex effects were apparent. Furthermore, a similar profile of schizophrenia was observed, with neurocognitive deficits most pronounced for executive functions, especially attention, as well as memory, social cognition, and motor speed relative to complex cognition and sensorimotor speed.

conclusionsResults support the feasibility of implementing a culturally adapted computerized neurocognitive battery in sub-Saharan African settings and provide evidence supporting the concurrent validity of the translated instrument. Thus, the PennCNB is implementable on a large scale in non-Western contexts, shows expected factor structure, and can detect cognitive deficits associated with neuropsychiatric disorders. Obtaining valid measures of cognition by nonspecialized proctors is especially suitable in resource-limited settings, where traditional testing is prohibitive. Future work should establish normative standards, test-retest reliability, and sensitivity to treatment. (PsycInfo Database Record (c) 2021 APA, all rights reserved).

Indexed as

CognitionExecutive FunctionHumansNeuropsychological TestsReproducibility of ResultsSouth Africa

Identifiers

PMID34242045
PMCPMC9531580
OpenAlexW3178343802

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.